Cargando…

Immunosuppression as a Hub for SARS-CoV-2 Mutational Drift

The clinical course of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is largely determined by host factors, with a wide range of outcomes. Despite an extensive vaccination campaign and high rates of infection worldwide, the pandemic pers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shapira, Guy, Patalon, Tal, Gazit, Sivan, Shomron, Noam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145566/ https://www.ncbi.nlm.nih.gov/pubmed/37112835 http://dx.doi.org/10.3390/v15040855

Ejemplares similares

A Data-Driven Strategy for Identifying Individuals Resistant to SARS-CoV-2 Virus under In-Household Exposure
por: Hen Gabzi, Roni, et al.
Publicado: (2022)

Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation
por: Gazit, Sivan, et al.
Publicado: (2023)

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
por: Mizrahi, Barak, et al.
Publicado: (2021)

Waning of SARS-CoV-2 booster viral-load reduction effectiveness
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022)

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
por: Prunas, Ottavia, et al.
Publicado: (2021)

Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
por: Prunas, Ottavia, et al.
Publicado: (2022)

Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization
por: Chodick, Gabriel, et al.
Publicado: (2021)

Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting
por: Ben-Tov, Amir, et al.
Publicado: (2022)

Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study
por: Adler, Limor, et al.
Publicado: (2022)

Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study
por: Fallach, Noga, et al.
Publicado: (2022)

Evaluating red blood cell distribution width from community blood tests as a predictor of hospitalization and mortality in adults with SARS-CoV-2: a cohort study
por: Banon, Tamar, et al.
Publicado: (2021)

Mpox Infection in a Developed Country: A Case Report
por: Patalon, Tal, et al.
Publicado: (2022)

Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
por: Grupel, Daniel, et al.
Publicado: (2021)

SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since Diagnosis
por: Levine-Tiefenbrun, Matan, et al.
Publicado: (2022)

SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021
por: Patalon, Tal, et al.
Publicado: (2022)

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998-2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS.
por: Tadmor, Tamar, et al.
Publicado: (2023)

Pregnancy Course of 10 Women Diagnosed with Chronic Lymphocytic Leukemia
por: Tadmor, Tamar, et al.
Publicado: (2023)

Mpox Patient Journey in Israel
por: Patalon, Tal, et al.
Publicado: (2023)

P1532: CLINICAL OUTCOMES OF COVID-19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)
por: Levy, Ilana, et al.
Publicado: (2023)

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
por: Prunas, Ottavia, et al.
Publicado: (2022)

Population differences in antibody response to SARS‐CoV‐2 infection and BNT162b2 vaccination
por: Shapira, Guy, et al.
Publicado: (2022)

Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents
por: Patalon, Tal, et al.
Publicado: (2023)

Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
por: Gazit, Sivan, et al.
Publicado: (2022)

Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022)

Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study
por: Yechezkel, Matan, et al.
Publicado: (2023)

De novo Emergence of SARS-CoV-2 Spike Mutations in Immunosuppressed Patients
por: Simons, Lacy M., et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

An Outbreak of Parvovirus B19 in Israel
por: Patalon, Tal, et al.
Publicado: (2023)

Immunosuppressants: SARS-CoV-2 pneumonia and SARS-CoV-2 infection: 2 case reports
Publicado: (2021)

Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift
por: Laroche, Adrien, et al.
Publicado: (2022)

Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
por: Mofaz, Merav, et al.
Publicado: (2022)

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign
por: Ben-Tov, Amir, et al.
Publicado: (2023)

Early Oxygen Treatment Measurements Can Predict COVID-19 Mortality: A Preliminary Study
por: Levi, Yosi, et al.
Publicado: (2022)

The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients
por: Higgins, Peter D R, et al.
Publicado: (2020)

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection
por: Ward, Daniel, et al.
Publicado: (2022)

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
por: Yuan, Meng, et al.
Publicado: (2021)

Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
por: Yuan, Meng, et al.
Publicado: (2021)

Elevated Expression of RGS2 May Underlie Reduced Olfaction in COVID-19 Patients
por: Avnat, Eden, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Fatal SARS-CoV-2 reinfection in an immunosuppressed patient on hemodialysis
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ll3aveok4oedj43br4a86hpfc